3rd Therapeutics Discovery
Convention Center, KSAU-HS. 10-11-12 October 2023
2023-10-10 03:00:00
Registration
Abstract Submission
  • ABSTRACT SUBMISSION
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
Prof. Hang Yang

Prof. Hang Yang

CAS Key Laboratory of Special Pathogens and Biosafety, Centre for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China


Hang Yang, Ph.D., Professor in Microbiology from the Wuhan Institute of Virology, Chinese Academy of Sciences. His research interests mainly focus on the discovery of novel antimicrobial agents, with a special emphasize on bacteriophage and phage-derived peptidoglycan hydrolases, i.e., endolysins, aimed to solve the antimicrobial resistant threats posed by highly pathogenic pathogens including staphylococci, streptococci, pseudomonas, Acinetobacter, and enterococci. Novel endolysins were discovered by high through-put screening and further be evaluated by in vitro assays and animal infection models as an effort to gain improved bactericidal performance and pharmacokinetic properties. For the phage part, he mainly interested in the interactions of phage with their bacterial hosts and their extended mammalian hosts. Currently, he is turning his attention to antiviral discoveries for highly pathogenic viruses, including SARS-CoV-2 and ASFV. His research was mainly funded by NSFC, CAS, and the local government. As an active researcher, he has served as an Invited Speaker for more than 4 international conferences and 6 domestic conferences and authored by more than 40 publications in top microbiology journals, including The EMBO Journal, Antimicrobial Agents and Chemotherapy, and International Journal of Pharmaceutics.

Therapeutics Discovery. 10-11-12 October 2023
Contact us

Contacts
KSAU-HS, Al Hars Al Watani, Ar Rimayah Riyadh 14611 Saudi Arabia
KAIMRC-Therapeutics@ngha.med.sa
LINKS
  • Therapeutics Discovery Conference
  • Objectives
  • About Therapeutics Discovery Conference
© 2021 KAIMRC - Advance Computing & Technologies, All Rights Reserved.